Trademark: 79165003
Word
ENVARSUS XR
Status Date
Wednesday, May 25, 2022
Registration Number
4839039
Registration Date
Tuesday, October 27, 2015
Filing Date
Thursday, October 16, 2014
Published for Opposition
Tuesday, August 11, 2015
40 [ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]
5 Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and threat, diseases and afflictions in the psychiatric field, ] pulmonological diseases [ and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]
44 [ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]
42 [ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]
The mark consists of three curved horizontal bands above the wording "ENVARSUS XR".
Color is not claimed as a feature of the mark.
"XR"
Mar 21, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 21, 2023
Teas Change Of Correspondence Received
Mar 21, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 21, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 21, 2023
Teas Change Of Owner Address Received
May 25, 2022
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
May 25, 2022
Case Assigned To Post Registration Paralegal
May 25, 2022
Registered - Sec. 71 Accepted & Sec. 15 Ack.
May 25, 2022
Case Assigned To Post Registration Paralegal
May 17, 2022
Teas Response To Office Action-Post Reg Received
May 24, 2022
Notice Of Cancellation Sec. 71 E-Mailed
May 23, 2022
Cancelled Section 71
Mar 28, 2022
Teas Change Of Correspondence Received
Mar 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2021
Office Action Issued Pou1
Nov 17, 2021
Case Assigned To Post Registration Paralegal
Oct 26, 2021
Teas Section 71 & 15 Received
Sep 18, 2021
Change Of Owner Received From Ib
May 21, 2021
Change Of Name/Address Rec'd From Ib
Oct 27, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Feb 7, 2020
New Representative At Ib Received
Sep 21, 2018
Correction From Ib Entered - No Review Required
Aug 3, 2018
Correction Transaction Received From Ib
Jan 18, 2018
Change Of Name/Address Rec'd From Ib
Sep 15, 2016
New Representative At Ib Received
Jul 15, 2016
Final Decision Transaction Processed By Ib
May 19, 2016
Final Disposition Notice Sent To Ib
May 19, 2016
Final Disposition Processed
Jan 27, 2016
Final Disposition Notice Created, To Be Sent To Ib
Oct 27, 2015
Registered-Principal Register
Sep 1, 2015
Correction From Ib Entered - No Review Required
Aug 21, 2015
Notification Processed By Ib
Aug 21, 2015
Correction Transaction Received From Ib
Aug 11, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 11, 2015
Published For Opposition
Aug 5, 2015
Notification Of Possible Opposition Sent To Ib
Aug 5, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 22, 2015
Notification Of Notice Of Publication E-Mailed
Jul 8, 2015
Law Office Publication Review Completed
Jul 7, 2015
Approved For Pub - Principal Register
Jul 2, 2015
Teas/Email Correspondence Entered
Jul 2, 2015
Correspondence Received In Law Office
Jun 26, 2015
Change Of Name/Address Rec'd From Ib
Jun 24, 2015
Assigned To Lie
Jun 17, 2015
Teas Response To Office Action Received
Jun 13, 2015
Refusal Processed By Ib
May 26, 2015
Non-Final Action Mailed - Refusal Sent To Ib
May 26, 2015
Refusal Processed By Mpu
May 24, 2015
Non-Final Action (Ib Refusal) Prepared For Review
May 23, 2015
Non-Final Action Written
May 19, 2015
Application Filing Receipt Mailed
May 16, 2015
Assigned To Examiner
May 15, 2015
New Application Office Supplied Data Entered
May 15, 2015
Limitation From Original Application Entered
May 14, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
